Scarica l'app Stockscreener
3.73
3.87%
-0.15
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.88
Aprire:
$3.9
Volume 24 ore:
1.44M
Relative Volume:
0.62
Capitalizzazione di mercato:
$403.67M
Reddito:
-
Utile/perdita netta:
$-258.08M
Rapporto P/E:
-1.3564
EPS:
-2.75
Flusso di cassa netto:
$-202.32M
1 W Prestazione:
+7.80%
1M Prestazione:
+11.01%
6M Prestazione:
+16.56%
1 anno Prestazione:
-68.36%
Intervallo 1D:
$3.71
$4.00
Intervallo di 1 settimana:
$3.454
$4.05
Portata 52W:
$2.19
$11.68
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Nome
Rocket Pharmaceuticals Inc
Settore
Industria
Telefono
646-440-9100
Indirizzo
350 FIFTH AVENUE, NEW YORK, NY
Confronta RCKT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.73 | 419.90M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-08-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-07-25 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-30 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-05-28 | Downgrade | Goldman | Neutral → Sell |
| 2025-05-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-05-28 | Downgrade | Jefferies | Buy → Hold |
| 2025-05-28 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | Downgrade | Needham | Buy → Hold |
| 2025-05-27 | Downgrade | TD Cowen | Buy → Hold |
| 2025-03-12 | Iniziato | BMO Capital Markets | Outperform |
| 2024-12-30 | Iniziato | Wedbush | Outperform |
| 2024-12-18 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-04-02 | Iniziato | Goldman | Neutral |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-02-01 | Iniziato | Morgan Stanley | Overweight |
| 2022-11-08 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-01 | Iniziato | BTIG Research | Buy |
| 2022-07-08 | Iniziato | Raymond James | Outperform |
| 2021-10-20 | Ripresa | Cowen | Outperform |
| 2021-03-02 | Iniziato | Stifel | Buy |
| 2021-02-18 | Iniziato | Needham | Buy |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-12-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-07-02 | Iniziato | JP Morgan | Overweight |
| 2020-06-25 | Ripresa | BofA/Merrill | Buy |
| 2020-06-01 | Ripresa | Oppenheimer | Outperform |
| 2019-11-06 | Iniziato | Chardan Capital Markets | Buy |
| 2019-09-26 | Iniziato | Piper Jaffray | Overweight |
| 2019-04-23 | Iniziato | Robert W. Baird | Outperform |
| 2019-03-15 | Iniziato | BofA/Merrill | Buy |
| 2019-02-05 | Iniziato | Oppenheimer | Outperform |
| 2018-09-13 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-07-10 | Iniziato | William Blair | Outperform |
Mostra tutto
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
Will Rocket Pharmaceuticals Inc. Equity Warrant stock rally after Fed decisionsJuly 2025 Movers & Precise Entry and Exit Recommendations - ulpravda.ru
How Rocket Pharmaceuticals Inc. Equity Warrant stock performs in weak economySector Leadership Analysis & Small Capital Trading Growth - bollywoodhelpline.com
Cash per share of Rocket Pharmaceuticals, Inc. Warrant 2023- on Rocket Pharmctc – NASDAQ:RCKTW - TradingView — Track All Markets
Why Rocket Pharmaceuticals Inc. stock could outperform in 2025Take Profit & Short-Term Swing Trade Alerts - ulpravda.ru
How rising interest rates impact Rocket Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Smart Allocation Stock Tips - ulpravda.ru
Can Rocket Pharmaceuticals Inc. Equity Warrant stock resist sector downturns2025 Historical Comparison & Free AI Powered Buy and Sell Recommendations - ulpravda.ru
What is the fair value of Rocket Pharmaceuticals Inc. stock nowEquity Performance Review & High Return Portfolio Growth - ulpravda.ru
Will Rocket Pharmaceuticals Inc. Equity Warrant stock continue upward momentumTrading Volume Trends & Superior Growth Trading - ulpravda.ru
Rocket Pharmaceuticals, Inc.Common Stock (NQ: RCKT - FinancialContent
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference - BioSpace
What analysts say about Rocket Pharmaceuticals Inc stockPortfolio Risk Assessment & Double Or Triple Capital - earlytimes.in
The Truth About Rocket Pharmaceuticals: Is RCKT About To Explode Or Crash? - AD HOC NEWS
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Cross Below 50 Day Moving AverageShould You Sell? - MarketBeat
Can Rocket Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryHigh Yield Income Stocks & Connect With Bulls, Avoid the Bears - bollywoodhelpline.com
Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program - Seeking Alpha
Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now? - MSN
Published on: 2025-12-24 06:58:20 - earlytimes.in
Will Rocket Pharmaceuticals Inc. Equity Warrant stock remain a Wall Street favoriteWeekly Profit Analysis & Long Hold Capital Preservation Plans - Улправда
How buybacks impact Rocket Pharmaceuticals Inc. stock valueMarket Rally & Expert Approved Momentum Trade Ideas - Улправда
Will Rocket Pharmaceuticals Inc. Equity Warrant stock outperform Nasdaq indexJuly 2025 Weekly Recap & Daily Entry Point Alerts - Bölüm Sonu Canavarı
Published on: 2025-12-20 17:40:18 - Улправда
Rocket Pharmaceuticals (NASDAQ:RCKT) Raised to Hold at TD Cowen - MarketBeat
Published on: 2025-12-20 11:21:01 - Улправда
Is Rocket Pharmaceuticals Inc. Equity Warrant stock dividend yield sustainableJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - Улправда
Can Rocket Pharmaceuticals Inc. Equity Warrant stock sustain institutional interest2025 Breakouts & Breakdowns & Weekly Top Performers Watchlists - Улправда
Can Rocket Pharmaceuticals Inc. stock hit analyst price targetsMarket Risk Report & Daily Entry Point Alerts - Улправда
What margin trends mean for Rocket Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Pullbacks & Real-Time Volume Spike Alerts - Улправда
Published on: 2025-12-19 17:54:30 - DonanımHaber
Will Rocket Pharmaceuticals Inc. stock rally after Fed decisions2025 Retail Activity & Long-Term Growth Portfolio Plans - DonanımHaber
Will Rocket Pharmaceuticals Inc. Equity Warrant stock maintain dividend yieldJuly 2025 Levels & Safe Swing Trade Setups - DonanımHaber
Stop Loss: Will Rocket Pharmaceuticals Inc. Equity Warrant stock rally after Fed decisionsWeekly Risk Report & Verified Short-Term Trading Plans - DonanımHaber
Rally Mode: What is the fair value of Rocket Pharmaceuticals Inc. stock nowJuly 2025 WrapUp & Low Drawdown Trading Techniques - ulpravda.ru
Why analysts remain bullish on Rocket Pharmaceuticals Inc. stockWeekly Trade Report & High Accuracy Trade Alerts - Улправда
Published on: 2025-12-18 21:01:52 - Улправда
Published on: 2025-12-18 16:59:15 - Улправда
Market Fear: Will Rocket Pharmaceuticals Inc. Equity Warrant stock continue upward momentum2025 Market Overview & Intraday High Probability Alerts - Улправда
Published on: 2025-12-18 16:13:14 - Улправда
Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders - Yahoo Finance
Analysts Are Bullish on Top Healthcare Stocks: Novan (NOVN), Palvella Therapeutics (PVLA) - The Globe and Mail
Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position - Finviz
Rocket Pharmaceuticals, Inc. (RCKT): A Bull Case Theory - MSN
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Maverick Capital Ltd. Has $20.49 Million Stock Position in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Working capital per share of Rocket Pharmaceuticals, Inc. – SWB:9IP1 - TradingView — Track All Markets
Rocket Pharmaceuticals (NASDAQ:RCKT) Share Price Passes Below Fifty Day Moving AverageHere's Why - MarketBeat
Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):